Iovance Biotherapeutics, Inc. (LON:0JDK)
London · Delayed Price · Currency is GBP · Price in USD 2.959
+0.099 (3.45%)
Jan 27, 2026, 5:03 PM GMT
Iovance Biotherapeutics Market Cap
Iovance Biotherapeutics has a market cap or net worth of 837.23 million as of January 27, 2026. Its market cap has decreased by -53.64% in one year.
Market Cap
837.23M
Enterprise Value
656.02M
Revenue
186.30M
Ranking
n/a
PE Ratio
n/a
Stock Price
2.96
Market Cap Chart
Since May 26, 2010, Iovance Biotherapeutics's market cap has increased from 62.39M to 837.23M, an increase of 1,241.98%. That is a compound annual growth rate of 18.02%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 23, 2026 | 772.04M | -4.12% |
| Dec 31, 2025 | 805.21M | -55.30% |
| Dec 31, 2024 | 1.80B | 10.29% |
| Dec 29, 2023 | 1.63B | 95.13% |
| Dec 30, 2022 | 837.09M | -62.16% |
| Dec 31, 2021 | 2.21B | -55.63% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 210.61B |
| GSK plc | 72.26B |
| Haleon | 33.83B |
| Smith & Nephew | 10.41B |
| Oxford Nanopore Technologies | 1.65B |
| Oxford Biomedica | 1.05B |
| Allergy Therapeutics | 724.69M |
| Spire Healthcare Group | 717.03M |